SYNLAB and Sonic have announced the sale of its Swiss business SYNLAB Suisse to Sonic Healthcare for a purchase price of CHF 150 million, having received the required approval of the Swiss antitrust authority. The closing
Tags :Slider
Evolva Holding announced that it had entered into a new agreement with Nice & Green (N&G) to replace an existing an equity-linked debt instrument issued by Evolva consisting of convertible notes issued in
GRO, a renowned Northern European private equity firm with an exclusive focus on high-quality B2B software companies with strong growth prospects, has made a strategic investment in Akselos, a creator of the world’s
Niederer Kraft Frey has advised bNovate Technologies as Swiss counsel on its CHF 12 million Series C financing round led by Emerald Technology Ventures, followed by existing shareholders. The funding will accelerate bNovate’s global expansion
Fahrzeug-Werke LUEG, one of the largest distribution and service partners of Daimler in Germany, has acquired the remaining stake in LUEG’s Swiss operations from Mercedes-Benz Automobil (MERBAG). Fahrzeug-Werke LUEG is one of the largest
Schellenberg Wittmer advised Swisscanto Private Equity in the CHF 8.3 million Series B financing of the renowned innovator in ultrasonic camera technology Distran, an ETH Zürich spin-off. The funding will be deployed to fuel the
Santander Corporate & Investment Banking has made a strategic equity investment into commodity trade finance platform Komgo, to accelerate the digital transformation of its trade and working capital products. Santander becomes a Komgo shareholder alongside
Alt. Inv. PCC Limited has established an issuance program for structured products – in particular, tracker certificates, actively-managed certificates (AMCs) and credit-linked notes (CLN) – pursuant to the Financial Services Act (FinSA). The prospectus was prepared under
Schellenberg Wittmer advised Geneva based Thematica in obtaining its FINMA license as manager of collective assets with the Swiss Financial Markets Supervisory Authority (FINMA). Founded in 2006, Thematica specializes in tailored investment solutions for professional clients
Santhera Pharmaceuticals Holding has announced the grant of an exclusive North America license for the commercialization of vamorolone to Catalyst Pharmaceuticals for a total consideration of up to USD 231 million
